L-Y Wu
Overview
Explore the profile of L-Y Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koppikar S, Oaknin A, Govind Babu K, Lorusso D, Gupta S, Wu L, et al.
ESMO Open
. 2023 Jan;
8(1):100774.
PMID: 36696825
The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer was published in 2022....
2.
Huang W, Huang G, Zhan Q, Chen J, Luo W, Wu L, et al.
Eur Rev Med Pharmacol Sci
. 2020 Dec;
24(22):11719-11728.
PMID: 33275241
Objective: It is widely known that the main white blood cell populations, and neutrophil to lymphocyte ratio (NLR), are involved in systemic inflammation. The usefulness of NLR measurements has been...
3.
Wu L, Huang K, Chuang F, Kung F, Yang T
J Minim Invasive Gynecol
. 2016 Sep;
22(6S):S66.
PMID: 27679304
No abstract available.
4.
Zhang J, Di Y, Wu L, He Y, Zhao T, Huang X, et al.
Free Radic Res
. 2014 Nov;
49(1):86-94.
PMID: 25363495
Oxidative injury is involved in many diseases, including ischemic and neurodegenerative diseases. Antioxidant drugs can be used to relieve the oxidative injury caused by these diseases; however, there are very...
5.
Cao Y, Xue J, Wu L, Jiang W, Hu P, Zhu J
Domest Anim Endocrinol
. 2011 Jul;
41(2):74-80.
PMID: 21741575
To understand leptin signaling pathway in the crucian carp (Carassius carassius), we cloned 3 leptin receptor isoform complementary DNAs (ie, the long form [cclpr-L], the short form [cclpr-s1], and the...
6.
Morre D, McClain N, Wu L, Kelly G, Morre D
Mol Biotechnol
. 2009 Jan;
42(1):100-9.
PMID: 19156549
Phenoxodiol is an experimental anticancer drug under development as a chemosensitizer intended to reverse multidrug resistance mechanisms in ovarian and prostate cancer cells to most standard cytotoxics. The putative molecular...
7.
Huang Y, Huang M, Li X, Li N, Wu L
Int J Gynecol Cancer
. 2007 Nov;
18(4):755-60.
PMID: 18021222
The aim of the present study was to evaluate the relationship between human papillomavirus (HPV) viral load and risk of cervical intraepithelial neoplasia (CIN) and cervical cancer. HPV viral load...
8.
Wang J, Shi Y, Wu L, Wang J, Yang S, Yang J, et al.
Int J Gynecol Cancer
. 2007 Sep;
18(4):825-32.
PMID: 17892453
The purpose of this study was to analyze prognostic factors for ovarian metastases from primary gastric cancer, helping establish optimal strategy in ameliorating survival for this entity. Clinical data of...
9.
Li N, Zhang X, Cai Y, Xu X, Zhang L, Pan K, et al.
Int J Gynecol Cancer
. 2006 Mar;
16 Suppl 1:172-8.
PMID: 16515586
The role of germline BRCA1 mutations in hereditary breast and ovarian cancer (HBOC) has been well established in women in Western countries. However, relatively few studies have been carried out...
10.
Hung Y, Chen Y, Pei D, Kuo S, Hsieh C, Wu L, et al.
Diabet Med
. 2005 Jul;
22(8):1024-30.
PMID: 16026368
Aim: To evaluate the effect of sibutramine on weight loss, insulin sensitivity and serum adiponectin levels in obese patients with Type 2 diabetes. Methods: This study is a randomized, double-blind,...